Navigation Links
Two-time Defending NASCAR Sprint Cup Series Champion Jimmie Johnson Joins the Team at CORD:USE Cord Blood Bank to Help Win the Race for Life
Date:2/12/2008

DAYTONA BEACH, Fla., Feb. 12 /PRNewswire/ -- CORD:USE Cord Blood Bank is proud to announce that two-time defending NASCAR Sprint Cup Series Champion Jimmie Johnson has joined its team. "We're honored to have this NASCAR superstar and terrific person on our team," states Dr. Edward Guindi, President and CEO of CORD:USE. Jimmie Johnson joins CORD:USE as a spokesperson to participate in its "Help Win the Race for Life(TM)" campaign.

"I'm excited about telling people the benefits of umbilical cord blood donation and cord blood stem cell treatments for people in life-or-death situations," says Johnson.

"The fact that umbilical cord blood, which is normally just thrown out after a baby's born, could be donated and used to save someone's life - that just blows me away. We've got over 75 million good-hearted NASCAR fans out there, and together we can make a real difference in CORD:USE's efforts to save lives. I support this with my whole heart, and you better believe when I'm a parent some day, it's something that I'm going to participate in first hand."

Jimmie Johnson joins other NASCAR greats Rusty Wallace and Michael Waltrip, who have played an active role in increasing public awareness of cord blood donation and the dozens of current applications utilizing cord blood stem cells in transplantation.

"They call it The Race for Life, and it's a race team I'm excited to be a part of. CORD:USE's team is made up of many of the top physicians and scientists in this important medical field, which is saving thousands of lives. You know me, every race I'm in, I want to win - and I'm especially determined to win this one," says Johnson.

Cord blood stem cells have already been used to treat more than 10,000 patients, saving thousands of people who would otherwise not have had a chance of survival. There are currently more than 70 different diseases that have been successfully treated utilizing cord blood stem cells.

About CORD:USE Cord Blood Bank

The CORD:USE Cord Blood Bank, headquartered in Orlando, Florida, has assembled a world-class team of scientists and physicians who are pioneers and world leaders in the fields of cord blood stem cell banking and transplantation. CORD:USE is creating a large, ethnically diverse, high- quality inventory of available cord blood stem cell units for the many patients in need of a potentially life-saving transplant. CORD:USE Cord Blood Bank has entered into agreements with hospitals across the country to provide parents the opportunity to donate their babies' cord blood. CORD:USE makes these cord blood units available to transplanters, throughout the country and around the world, as a critical component in their patients' treatment. CORD:USE lists all of its units on the National Marrow Donor Program's Registry. For more information, please visit our website http://www.corduse.com .


'/>"/>
SOURCE CORD:USE Cord Blood Bank
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Good Neighbor Pharmacy Joins with Diversified Racing Solutions to Enter NASCAR Nationwide Series in 2008
2. Hyperion Therapeutics Secures $40 Million In Series B Round
3. Enobia Pharma Raises $40.1 Million Series B Financing
4. OpGen Announces $23.6 Million Series A Financing
5. Amyris Biotechnologies Announces $70 Million Series B Round
6. Apollo Endosurgery, Inc. Secures $11.5 Million in Series A Financing.
7. Response Genetics CEO to Discuss Advances in Optimizing Therapy through Pharmacogenomics as Part of a Series of Presentations at AACR-NCI-EORTC International Conference
8. VisEn Medical Raises $7 Million in Series B Financing
9. Nikon Unveils the Eclipse Ti Inverted Microscope Series at The Society for Neroscience Annual Meeting
10. BioVex Closes Second Round of Series E Financing
11. Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):